Parexel chief named ACRO chairman

Parexel ($PRXL) CEO Josef von Rickenbach will serve as chairman of industry group ACRO this year, succeeding PharmaNet CEO Jeffrey McMullen. "As incoming chairman, I look forward to continuing the great momentum initiated by my predecessor to help ACRO and its members build and strengthen public understanding and confidence in clinical research," von Rickenbach said in a statement. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.